Amoebic forms of Blastocystis spp. - evidence for a pathogenic role

Particle and Fibre Toxicology

Suresh Kumar Govind¹  Arutchelvan Rajamanikam¹ 

[1] Department of Parasitology, University of Malaya, Kuala Lumpur 50603, Malaysia

关键词: Gastrointestinal;    Amoebic form;    Protease activity;    Blastocystis spp;   

Others  :  824290
DOI  :  10.1186/1756-3305-6-295

 received in 2013-10-03, accepted in 2013-10-03,  发布年份 2013

【 摘 要 】

Background

Blastocystis spp. are one of the most prevalent parasites isolated from patients suffering from diarrhea, flatulence, constipation and vomiting. It’s pathogenicity and pathophysiology remains controversial to date. Protease activity and amoebic forms have been reported previously in symptomatic isolates but there has been no conclusive evidence provided to correlate the protease activity and any specific life cycle stage of the parasite thus far.

Methods

Symptomatic isolates with amoebic form were tested for protease activity and compared with symptomatic and asymptomatic isolates without amoebic form for 10 days culture period.

Results

The present study demonstrates an elevated protease activity in cultures having a higher percentage of amoebic forms seen in symptomatic isolates. The growth curve demonstrated a significantly (p < 0.05) higher average number of parasite counts in asymptomatic compared to symptomatic isolates. Symptomatic isolates showed amoebic forms with percentages ranging from 5% to 17%. Elevated protease activity was demonstrated in isolates that had higher percentages of amoebic forms with intense bands at higher molecular weight proteases (60 – 100 kDa). As days of culture proceeded, the protease quantification also showed a steady increase.

Conclusion

This study elucidates a correlation between protease activity and percentage of amoebic forms. The finding implies that these forms could play a role in exacerbation of intestinal symptoms during Blastocystis spp. infection.

【 授权许可】

   
2013 Rajamanikam and Govind; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]Hussainqadri SM, Al-Okaili GA, Al-Dayel F: Clinical significance of Blastocystis hominis. J Clin Microbiol 1989, 27:2407-2409.
• [2]Tan KSW: New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 2008, 21:639-665.
• [3]Stenzel DJ, Boreham PFL: Blastocystis hominis revisited. Clin Microbiol Rev 1996, 9:563-584.
• [4]Horiki N, Maruyama M, Fujita Y, Yonekura T, Minato S, Kaneda Y: Epidemiologic survey of Blastocystis hominis infection in Japan. Am J Trop Med Hyg 1997, 56:370-374.
• [5]Pegelow K, Gross R, Pietrzik K, Lukito W, Richards A, Fryauff DJ: Parasitological and nutritional situation of school children in the Sukaraja district, West Java. Indonesia. Southeast Asian J Trop Med Public Health 1997, 28:173-190.
• [6]Tan TC, Tan PC, Sharma R, Sugnaseelan S, Suresh KG: Genetic diversity of caprine Blastocystis from Peninsular Malaysia. Parasitol Res 2012, 112:85-89.
• [7]Souppart L, Sanciu G, Cian A, Wawrzyniak I, Delbac F, Capron M, Dei-Cas E, Boorom K, Delhaes L, Viscogliosi E: Molecular epidemiology of human Blastocystis isolates in France. Parasitol Res 2009, 105:413-421.
• [8]Dogruman-Al F, Dagci H, Yoshikawa H, Kurt Ö, Demirel M: A possible link between subtype 2 and asymptomatic infections of Blastocystis hominis. Parasitol Res 2008, 103:685-689.
• [9]Li LH, Zhang XP, Lv S, Zhang L, Yoshikawa H, Wu Z, Steinmann P, Utzinger J, Tong XM, Chen SH, Zhou XN: Cross-sectional surveys and subtype classification of human Blastocystis isolates from four epidemiological settings in China. Parasitol Res 2007, 102:83-90.
• [10]Kaneda Y, Horiki N, Cheng X-J, Fujita Y, Maruyama M, Tachibana H: Ribodemes of Blastocystis hominis isolated in japan. Am J Trop Med Hyg 2001, 65:393-396.
• [11]Moosavi A, Haghighi A, Mojarad EN, Zayeri F, Alebouyeh M, Khazan H, Kazemi B, Zali MR: Genetic variability of Blastocystis sp. isolated from symptomatic and asymptomatic individuals in Iran. Parasitol Res 2012, 111:2311-2315.
• [12]Böhm-Gloning B, Knobloch J, Walderich B: Five subgroups of Blastocystis hominis from symptomatic and asymptomatic patients revealed by restriction site analysis of PCR-amplified 16S-like rDNA. Trop Med Int Health 1997, 2:771-778.
• [13]Yoshikawa H, Abe N, Wu Z: PCR-based identification of zoonotic isolates of Blastocystis from mammals and birds. Microbiology 2004, 150:1147-1151.
• [14]Özyurta M, Kurtb Ö, Mølbakc K, Nielsend HV, Haznedaroglua T, Stensvold CR: Molecular epidemiology of Blastocystis infections in Turkey. Parasitol Int 2008, 57:300-306.
• [15]Tan TC, Suresh KG: Predominance of amoeboid forms of Blastocystis hominis in isolates from symptomatic patients. Parasitol Res 2006, 98:189-193.
• [16]Tan TC, Suresh KG: Amoeboid form of Blastocystis hominis—a detailed ultrastructural insight. Parasitol Res 2006, 99:737-742.
• [17]Stenzel DJ, Boreham PFL, McDougall R: Ultrastructure of Blastocystis hominis in human stool samples. Int J Parasitol 1991, 21:807-812.
• [18]Lanuza M, Carbajal J, Villar J, Borrás R: Description of an improved method for Blastocystis hominis culture and axenization. Parasitol Res 1997, 83:60-63.
• [19]Sio SWS, Puthia MK, Lee ASY, Lu J, Tan KSW: Protease activity of Blastocystis hominis. Parasitol Res 2006, 99:126-130.
• [20]Abdel-Hameed DM, Hassanin OM: Proteaese activity of Blastocystis hominis subtype3 in symptomatic and asymptomatic patients. Parasitol Res 2011, 109:321-327.
• [21]Puthia MK, Lu J, Tan KSW: Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells in an NF-kB-dependent manner. Eukaryot Cell 2008, 7:435-443.
• [22]Puthia MK, Vaithilingam A, Lu J, Tan KSW: Degradation of human secretory immunoglobulin a by Blastocystis. Parasitol Res 2005, 97:386-389.
• [23]Mirza H, Tan KSW: Blastocystis exhibits inter- and intra-subtype variation in cystiene protease. Parasitol Res 2009, 104:355-361.
• [24]Suresh K, Ng GC, Ho LC, Yap EH, Singh M: Differentiation of the various stages of Blastocystis hominis by acridine orange staining. Int J Parasitol 1994, 24:605-606.
• [25]Que X, Reed SL: Cysteine proteinases and the pathogenesis of amebiasis. Clin Microbiol Rev 2000, 13:196-206.
• [26]Yadav M, Dubey ML, Gupta I, Bhatti G, Malla N: Cysteine proteinase 30 in clinical isolates of T. vaginalis from symptomatic and asymptomatic infected women. Exp Parasitol 2007, 116:399-406.
• [27]Khan NA, Jarroll EL, Panjwani N, Cao Z, Paget TA: Proteases as markers for differentiation of pathogenic and nonpathogenic species of acanthamoeba. J Clin Microbiol 2000, 38:2858-2861.
• [28]Wawrzyniak I, Texier C, Poirier P, Viscogliosi E, Tan KSW, Delbac F, Alaoui HE: Characterization of two cysteine proteases secreted by Blastocystis ST7, a human intestinal parasite. Parasitol Int 2012, 61:437-442.
• [29]Barrios-Ceballos MP, Martínez-Gallardo NA, Anaya-Velázquez F, Mirelman D, Padilla-Vaca F: A novel protease from Entamoeba histolytica homologous to members of the family S28 of serine proteases. Exp Parasitol 2005, 110:270-275.
• [30]Doyle PS, Zhou YM, Hsieh I, Greenbaum CD, McKerrow JH, Engel JC: The trypanosoma cruzi protease cruzain mediates immune evasion. PLoS Pathog 2011, 7:1-11.
• [31]Sissons J, Alsam S, Goldsworthy G, Lightfoot M, Jarroll EL, Khan NA: Identification and properties of proteases from an Acanthamoeba isolate capable of producing granulomatous encephalitis. BMC Microbiol 2006, 6:42-50. BioMed Central Full Text
• [32]Singh M, Suresh K, Ho LC, Ng GC, Yap EH: Elucidation of the life cycle of the intestinal protozoan Blastocystis hominis. Parasitol Res 1995, 81:446-450.
• [33]He N, Zhang Y, Hong M, Cong M: Morphological and ultrastructural observation of Blastocystis hominis. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2001, 19:169-172.
• [34]Zhang X, Zhang S, Qiao J, Wu X, Zhao L, Liu Y, Fan X: Ultrastructural insights into morphology and reproductive mode of Blastocystis hominis. Parasitol Res 2012, 110:1165-1172.
• [35]Scanlan PD: Blastocystis: past pitfalls and future perspectives. Trends Parasitol 2012, 28:327-334.
• [36]Carvalho TB, David EB, Coradi ST, Guimarães S: Protease activity in extracellular products secreted in vitro by trophozoites of Giardia duodenalis. Parasitol Res 2008, 104:185-190.
• [37]Tan TC, Suresh KG, Smith HV: Phenotypic and genotypic characterisation of Blastocystis hominis isolates implicates subtype 3 as a subtype with pathogenic potential. Parasitol Res 2008, 104:85-93.
• [38]Schulte W, Scholze H: Action of the major protease from Entamoeba histolytica on proteins of the extracellular matrix. J Protozool 1989, 36:538-543.
• [39]Samudi C, Kumar S, Anitab ZB, Kuppusamy UR: Infections of Blastocystis hominis and microsporidia in cancer patients: are they opportunistic? Trans R Soc Trop Med Hyg 2012, 106:267-269.